Skip to content
Emerging Research

Kisspeptin

Kisspeptin is a family of neuropeptides encoded by the KISS1 gene that acts as a master regulator of the reproductive system.

Also known as: KISS1 Gene Product, Reproductive Neuropeptide

Typical Dose 100-200mcg
Storage Refrigerate reconstituted; store lyophilized powder away from light
How Often Single dose or 2-3x/week

Overview

Kisspeptin is a family of neuropeptides encoded by the KISS1 gene that acts as a master regulator of the reproductive system. It potently stimulates gonadotropin-releasing hormone (GnRH) neurons, making it essential for puberty initiation, fertility, and reproductive function. Research explores its therapeutic potential for infertility, low libido, and reproductive disorders.

Key Benefits

  • Hypogonadotropic Hypogonadism
  • IVF Ovulation Trigger
  • Hypothalamic Amenorrhea

Potent stimulation of reproductive hormones (LH/FSH), restoration of natural testosterone production, fertility enhancement, and sexual function support. Suitable for addressing hypogonadism and reproductive disorders.

Mechanism of Action

Kisspeptin binds to GPR54/KISS1R receptors on GnRH neurons in the hypothalamus, triggering pulsatile release of GnRH. This stimulates pituitary secretion of LH and FSH, which in turn promote gonadal steroid production and reproductive function.

Pharmacokinetics

Peak plasma concentration: 3 min. Elimination half-life: 28 min. Largely cleared by: ~2.3 hrs.

Research Protocols Injectable

GoalDoseFrequencyRoute
Gonadotropin stimulation100-200mcgSingle dose or 2-3x/weekSubcutaneous
Fertility support0.4-1.0 nmol/kg (50-150mcg)As directed by physicianSubcutaneous
Sexual function1 nmol/kg/h75 min IV infusion (clinical)Subcutaneous
Research protocols0.3-10 nmol/kgVariable by protocolSubcutaneous

Research protocols from published literature — not dosing recommendations.

Peptide Interactions

  • GnRH — Synergistic: Kisspeptin stimulates GnRH release, working upstream in the reproductive axis
  • hCG — Alternative: Kisspeptin may serve as safer alternative to hCG for IVF ovulation trigger
  • Testosterone — Compatible: May help restore natural testosterone production through LH stimulation
  • Estrogen — Compatible: Kisspeptin function is modulated by sex steroids in feedback loops

Peptide Instructions Injectable

Supplies:

  • Bacteriostatic water (BAC water) or sterile water
  • Insulin syringes (0.5-1mL)
  • Alcohol swabs
  • Peptide vial
  • Sterile work surface

How to Reconstitute Injectable

  1. 1Clean work area and hands thoroughly with alcohol
  2. 2Calculate required BAC water volume using calculator below
  3. 3Draw calculated BAC water into syringe
  4. 4Inject slowly down vial side (not directly onto powder)
  5. 5Gently swirl until completely dissolved (never shake)
  6. 6Store reconstituted solution in refrigerator at 2-8°C
  7. 7Use within 7 days for KP-10, up to 14 days for KP-54

What to Expect Injectable

Hours 2-5: LH surge peaks (3-5x baseline). Hours 12-14: LH returns to baseline. Day 1-2: Testosterone/estradiol increase in response to LH. Week 2-4: Potential improvements in sexual function and libido. Important: Do NOT use daily - causes receptor desensitization.

Side Effects & Safety

Use sterile injection technique to prevent infection. CRITICAL: Avoid daily administration - causes tachyphylaxis (desensitization). Recommended frequency: 2-3x per week maximum. May cause cardiovascular effects (vasoconstriction) - caution with heart disease. Not recommended during pregnancy or breastfeeding. Consult reproductive endocrinologist for fertility applications. Monitor for signs of ovarian hyperstimulation in women.

Use sterile injection technique to prevent infection. CRITICAL: Avoid daily administration - causes tachyphylaxis (desensitization). Recommended frequency: 2-3x per week maximum. May cause cardiovascular effects (vasoconstriction) - caution with heart disease. Not recommended during pregnancy or breastfeeding. Consult reproductive endocrinologist for fertility applications. Monitor for signs of ovarian hyperstimulation in women.

Community Insights

Kisspeptin should be stored at Fridge 2-8°C, use within 7-14 days.

Molecular Information

Molecular Weight 1,213.42 Da (KP-10) / 6,087 Da (KP-54)
Length 10
Type Neuropeptide family (RFamide)
Sequence Kisspeptin-10: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 | Kisspeptin-54: 54 amino acid C-terminal fragment

References

  1. Intranasal kisspeptin administration rapidly stimulates gonadotropin release in humans Abbara, A., Horton, R., Turnbull, P., et al. · eBioMedicine 2025
  2. Emerging Therapeutic Potential of Kisspeptin and Neurokinin B Mills, E.G.A., Dhillo, W.S., Comninos, A.N. · Endocrine Reviews 2024
  3. Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder Comninos, A.N., Wall, M.B., Demetriou, L., et al. · JAMA Network Open 2023
  4. Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder Comninos, A.N., Wall, M.B., Demetriou, L., et al. · JAMA Network Open 2022
  5. Use of kisspeptin to trigger oocyte maturation during in vitro fertilisation (IVF) treatment Abbara, A., Eng, P.C., Phylactou, M., et al. · Frontiers in Endocrinology 2022
  6. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability Dong, F., Zhao, Y., Li, W., et al. · Journal of the American Heart Association 2017
  7. Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization Jayasena, C.N., Abbara, A., Comninos, A.N., et al. · Journal of Clinical Investigation 2014
  8. Impaired kisspeptin signaling decreases metabolism and promotes glucose intolerance and obesity Tolson, K.P., Garcia, C., Yen, S., et al. · Journal of Clinical Investigation 2014
  9. KISS1/KISS1R in cancer: Friend or foe? Guzman, S., Brackstone, M., Radovick, S., Babwah, A.V., Bhattacharya, M.M. · Frontiers in Endocrinology 2012
  10. Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system Mead, E.J., Maguire, J.J., Kuc, R.E., Davenport, A.P. · British Journal of Pharmacology 2007
  11. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54 de Roux, N., Genin, E., Carel, J.C., et al. · Proceedings of the National Academy of Sciences 2003
  12. The GPR54 gene as a regulator of puberty Seminara, S.B., Messager, S., Chatzidaki, E.E., et al. · New England Journal of Medicine 2003

Research reference only. Not medical advice.